Sarepta Therapeutics Announces Pricing of $100.7 Million Public Offering of Common Stock

[Business Wire] – Sarepta Therapeutics, Inc. , a developer of innovative RNA-based therapeutics, today announced that it has priced an underwritten public offering of an aggregate of 2,650,000 shares of its common stock at a price to the public of $38.00 more

View todays social media effects on SRPT

View the latest stocks trending across Twitter. Click to view dashboard

See who Sarepta is hiring next, click here to view